Metabolic consequences of atypical antipsychotic drugs.

Metabolic consequences of atypical antipsychotic drugs.

Item
http://www.wikidata.org/entity/Q35199632
Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance.Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: the Graz Endocrine Causes of Hypertension studyMetabolic side effects of atypical antipsychotics in children: a literature review.Tic disorders: from pathophysiology to treatment.Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders.The use of antipsychotics in children and adolescents with bipolar disorders.A UK audit of screening for the metabolic side effects of antipsychotics in community patients.Use of risperidone as augmentation treatment for major depressive disorder.A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania.Metabolic Syndrome Screening and Assertive Community Treatment: A Quality Improvement Study.Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain.
P2860

Metabolic consequences of atypical antipsychotic drugs.

Item
http://www.wikidata.org/entity/Q35199632
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Metabolic consequences of atypical antipsychotic drugs.
@ast
Metabolic consequences of atypical antipsychotic drugs.
@en
type
label
Metabolic consequences of atypical antipsychotic drugs.
@ast
Metabolic consequences of atypical antipsychotic drugs.
@en
prefLabel
Metabolic consequences of atypical antipsychotic drugs.
@ast
Metabolic consequences of atypical antipsychotic drugs.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Metabolic consequences of atypical antipsychotic drugs.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698